INPLASY202430114

Efficacy and Safety of neoadjuvant tislelizumab plus chemotherapy for the Treatment of non-small cell lung cancer: A Single-Arm Meta-Analysis Among Chinese Patients

Keywords: Neoadjuvant, perioperative, tislelizumab,BGB-A 317 , Non-SmallCell Lung Cancer, adenocarcinoma, squamous carcinoma.

Download PDF - 202430114

Review Status: Ongoing